Multiple Cytochrome b Mutations May Cause Atovaquone Resistance | Zendy

Steven R. Meshnick | Zendy; Bernard L. Trumpower | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Multiple Cytochrome b Mutations May Cause Atovaquone Resistance

Author(s) -

Steven R. Meshnick,

Bernard L. Trumpower

Publication year - 2005

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/427782

Subject(s) - atovaquone , cytochrome b , genetics , biology , mutation , virology , medicine , microbiology and biotechnology , gene , immunology , mitochondrial dna , malaria , plasmodium falciparum

Phillips and Lampe [1]. Given the rapid changes in HAART over the past decade— including marked improvements in potency, tolerability, and dosing frequency, it is doubtful that we will ever have an observational cohort in which patients receive the same therapy for 10 years. New therapies are certain to emerge that will be adopted, and the details of the research questions will change over time.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research